Related Experiment Video
Updated: May 15, 2026
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Peripheral neuropathy in patients with myotonic dystrophy type 1
Stojan Peric1, Vidosava Rakocevic Stojanovic, Ana Nikolic
1Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia. stojanperic@gmail.com
Neurological Research
|January 23, 2013
Summary
Peripheral neuropathy (PNP) affects one-third of patients with myotonic dystrophy type 1 (DM1), often presenting as motor and demyelinating types. Factors like male gender, older age, and metabolic issues are associated with PNP in DM1.
Area of Science:
- Neurology
- Genetics
- Metabolic Disorders
Background:
- Myotonic dystrophy type 1 (DM1) is a multisystem disorder.
- Peripheral neuropathy (PNP) is a known complication, but its frequency and characteristics in DM1 require further elucidation.
Purpose of the Study:
- To determine the prevalence and types of PNP in DM1 patients.
- To identify clinical and metabolic factors associated with PNP in DM1.
Main Methods:
- Nerve conduction studies were performed on 111 adult DM1 patients.
- Sural, peroneal, and median nerves of both limbs were assessed.
Main Results:
- PNP was observed in one-third of DM1 patients, more common in males and older individuals.
- Motor and demyelinating PNP were the most frequent types.
- PNP was associated with glucose intolerance, diabetes mellitus, higher BMI, dyslipidemia, and longer disease duration.
Conclusions:
- PNP is a common finding in DM1, characterized by motor and demyelinating features.
- Male gender, advanced age, disease duration, and metabolic abnormalities are linked to PNP in DM1.
- These findings highlight the importance of screening for PNP in DM1 patients.
Related Concept Videos
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...